• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种贝叶斯方法,用于估计在整群随机试验中因死亡而截断结局时的生存平均因果效应。

A Bayesian Approach for Estimating the Survivor Average Causal Effect When Outcomes Are Truncated by Death in Cluster-Randomized Trials.

出版信息

Am J Epidemiol. 2023 Jun 2;192(6):1006-1015. doi: 10.1093/aje/kwad038.

DOI:10.1093/aje/kwad038
PMID:36799630
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10236525/
Abstract

Many studies encounter clustering due to multicenter enrollment and nonmortality outcomes, such as quality of life, that are truncated due to death-that is, missing not at random and nonignorable. Traditional missing-data methods and target causal estimands are suboptimal for statistical inference in the presence of these combined issues, which are especially common in multicenter studies and cluster-randomized trials (CRTs) carried out among the elderly or seriously ill. Using principal stratification, we developed a Bayesian estimator that jointly identifies the always-survivor principal stratum in a clustered/hierarchical data setting and estimates the average treatment effect among them (i.e., the survivor average causal effect (SACE)). In simulations, we observed low bias and good coverage with our method. In a motivating CRT, the SACE and the estimate from complete-case analysis differed in magnitude, but both were small, and neither was incompatible with a null effect. However, the SACE estimate has a clear causal interpretation. The option to assess the rigorously defined SACE estimand in studies with informative truncation and clustering can provide additional insight into an important subset of study participants. Based on the simulation study and CRT reanalysis, we provide practical recommendations for using the SACE in CRTs and software code to support future research.

摘要

许多研究由于多中心招募和非致死性结局(如生活质量)而存在聚类,这些结局因死亡而截断——即缺失不是随机的,且不可忽略。在存在这些综合问题的情况下,传统的缺失数据方法和目标因果估计量对于统计推断并不理想,这些问题在多中心研究和在老年人或重病患者中进行的集群随机试验(CRTs)中尤为常见。我们使用主要分层法开发了一种贝叶斯估计量,该估计量可在聚类/分层数据环境中共同识别始终存活的主要分层,并估计其中的平均治疗效果(即幸存者平均因果效应(SACE))。在模拟中,我们观察到我们的方法具有低偏差和良好的覆盖率。在一个有启发性的 CRT 中,SACE 和完全案例分析的估计值在大小上有所不同,但两者都很小,且均与零效应不矛盾。然而,SACE 估计值具有明确的因果解释。在具有信息截断和聚类的研究中评估严格定义的 SACE 估计量的选项可以为研究参与者的一个重要子集提供更多的见解。基于模拟研究和 CRT 重新分析,我们为 CRT 中使用 SACE 提供了实用建议,并提供了支持未来研究的软件代码。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9650/10236525/66654e70a089/kwad038f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9650/10236525/66654e70a089/kwad038f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9650/10236525/66654e70a089/kwad038f1.jpg

相似文献

1
A Bayesian Approach for Estimating the Survivor Average Causal Effect When Outcomes Are Truncated by Death in Cluster-Randomized Trials.一种贝叶斯方法,用于估计在整群随机试验中因死亡而截断结局时的生存平均因果效应。
Am J Epidemiol. 2023 Jun 2;192(6):1006-1015. doi: 10.1093/aje/kwad038.
2
A mixed model approach to estimate the survivor average causal effect in cluster-randomized trials.混合模型方法估计群组随机临床试验中的幸存者平均因果效应。
Stat Med. 2024 Jan 15;43(1):16-33. doi: 10.1002/sim.9939. Epub 2023 Nov 20.
3
Weighting methods for truncation by death in cluster-randomized trials.整群随机试验中因死亡导致截尾的加权方法。
Stat Methods Med Res. 2025 Mar;34(3):473-489. doi: 10.1177/09622802241309348. Epub 2025 Jan 31.
4
Survivor Average Causal Effects for Continuous Time: A Principal Stratification Approach to Causal Inference With Semicompeting Risks.连续时间下幸存者的平均因果效应:一种用于半竞争风险因果推断的主分层方法
Biom J. 2025 Apr;67(2):e70041. doi: 10.1002/bimj.70041.
5
A comparison of methods to estimate the survivor average causal effect in the presence of missing data: a simulation study.存在缺失数据时估计幸存者平均因果效应的方法比较:一项模拟研究。
BMC Med Res Methodol. 2019 Dec 3;19(1):223. doi: 10.1186/s12874-019-0874-x.
6
The balanced survivor average causal effect.平衡幸存者平均因果效应。
Int J Biostat. 2013 May 7;9(2):291-306. doi: 10.1515/ijb-2012-0013.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
Assessing the ratio of means as a causal estimand in clinical endpoint bioequivalence studies in the presence of intercurrent events.在存在并发事件的情况下,评估均值比作为临床终点生物等效性研究中的因果估计量。
Stat Med. 2019 Nov 30;38(27):5214-5235. doi: 10.1002/sim.8367. Epub 2019 Oct 17.
9
Clarifying selection bias in cluster randomized trials.阐明整群随机试验中的选择偏倚。
Clin Trials. 2022 Feb;19(1):33-41. doi: 10.1177/17407745211056875. Epub 2021 Dec 11.
10
Identification and estimation of survivor average causal effects.幸存者平均因果效应的识别与估计
Stat Med. 2014 Sep 20;33(21):3601-28. doi: 10.1002/sim.6181. Epub 2014 May 29.

引用本文的文献

1
Bayesian Analysis of Time-To-Event Data in a Cluster-Randomized Trial: Major Outcomes With Personalized Dialysate TEMPerature (MyTEMP) Trial.群组随机试验中事件发生时间数据的贝叶斯分析:个性化透析液温度(MyTEMP)试验的主要结果
Can J Kidney Health Dis. 2025 Jun 28;12:20543581251341710. doi: 10.1177/20543581251341710. eCollection 2025.
2
Weighting methods for truncation by death in cluster-randomized trials.整群随机试验中因死亡导致截尾的加权方法。
Stat Methods Med Res. 2025 Mar;34(3):473-489. doi: 10.1177/09622802241309348. Epub 2025 Jan 31.
3
Randomized in error in pragmatic clinical trials.

本文引用的文献

1
Impact of complex, partially nested clustering in a three-arm individually randomized group treatment trial: A case study with the wHOPE trial.三臂个体随机分组治疗试验中复杂、部分嵌套聚类的影响:以 WHOPE 试验为例的案例研究。
Clin Trials. 2022 Feb;19(1):3-13. doi: 10.1177/17407745211051288. Epub 2021 Oct 24.
2
Missing not at random in end of life care studies: multiple imputation and sensitivity analysis on data from the ACTION study.在生命终末期关怀研究中并非随机缺失:来自 ACTION 研究的数据的多重插补和敏感性分析。
BMC Med Res Methodol. 2021 Jan 9;21(1):13. doi: 10.1186/s12874-020-01180-y.
3
Essential Ingredients and Innovations in the Design and Analysis of Group-Randomized Trials.
实用临床试验中的随机化错误。
Contemp Clin Trials. 2025 Jan;148:107764. doi: 10.1016/j.cct.2024.107764. Epub 2024 Nov 26.
群组随机试验设计与分析的基本要素和创新。
Annu Rev Public Health. 2020 Apr 2;41:1-19. doi: 10.1146/annurev-publhealth-040119-094027. Epub 2019 Dec 23.
4
A comparison of methods to estimate the survivor average causal effect in the presence of missing data: a simulation study.存在缺失数据时估计幸存者平均因果效应的方法比较:一项模拟研究。
BMC Med Res Methodol. 2019 Dec 3;19(1):223. doi: 10.1186/s12874-019-0874-x.
5
What are the statistical implications of treatment non-compliance in cluster randomized trials: A simulation study.群组随机对照试验中治疗不依从的统计学意义:一项模拟研究。
Stat Med. 2019 Nov 20;38(26):5071-5084. doi: 10.1002/sim.8351. Epub 2019 Oct 3.
6
Measuring and Analyzing Length of Stay in Critical Care Trials.测量和分析重症监护试验中的住院时间。
Med Care. 2019 Sep;57(9):e53-e59. doi: 10.1097/MLR.0000000000001059.
7
Sample size calculations for group randomized trials with unequal group sizes through Monte Carlo simulations.通过蒙特卡罗模拟对组间大小不等的群组随机试验进行样本量计算。
Stat Methods Med Res. 2018 Sep;27(9):2569-2580. doi: 10.1177/0962280216682775. Epub 2016 Dec 15.
8
Estimation of causal effects in clinical endpoint bioequivalence studies in the presence of intercurrent events: noncompliance and missing data.在存在并发事件(不依从性和缺失数据)的情况下,临床终点生物等效性研究中因果效应的估计
J Biopharm Stat. 2019;29(1):151-173. doi: 10.1080/10543406.2018.1489408. Epub 2018 Jul 11.
9
Statistical methods to compare functional outcomes in randomized controlled trials with high mortality.在高死亡率的随机对照试验中比较功能结局的统计方法。
BMJ. 2018 Jan 3;360:j5748. doi: 10.1136/bmj.j5748.
10
Review of Recent Methodological Developments in Group-Randomized Trials: Part 1-Design.群组随机试验近期方法学进展综述:第1部分——设计
Am J Public Health. 2017 Jun;107(6):907-915. doi: 10.2105/AJPH.2017.303706. Epub 2017 Apr 20.